Publications by authors named "Maxim Grymonprez"

Claim this Profile
T
Treatable moments for smoking cessation in asthma and COPD: a nationwide cohort study.
Delphine Vauterin, Adam Edward Lang, Kristiaan Proesmans, Maxim Grymonprez, Lies Lahousse

BMJ Open Respir Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in Belgium.
Frauke Van Vaerenbergh, Delphine Vauterin, Maxim Grymonprez, Lowie E G W Vanfleteren, Guy Brusselle

Lancet Reg Health Eur· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.
Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez, Guy Joos, Lies Lahousse

ERJ Open Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Comprehensive Approach to Current Atrial Fibrillation Challenges: Insights from an Expert Panel.
Carlos Escobar, Miguel Camafort, Elena Fortuny, Maxim Grymonprez, Alejandro Isidoro Pérez-Cabeza

J Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.
Maxim Grymonprez, Stephane Steurbaut, Andreas Capiau, Delphine Vauterin, Frauke Van Vaerenbergh

Cardiovasc Drugs Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.
Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut, Koen Boussery, Els Mehuys

Cardiovasc Drugs Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intake Patterns and Experiences of Patients Using Direct Oral Anticoagulants Measured by Electronic Monitoring in Community Pharmacies.
Sara Desmaele, Andreas Capiau, Maxim Grymonprez, Antoine Pironet, Stephane Steurbaut

Patient Prefer Adherence· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis.
Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez, Anna Vanoverschelde, Lies Lahousse

BMJ Open Respir Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study.
Cheima Amrouch, Davide Liborio Vetrano, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Maxim Grymonprez

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort study.
Kristiaan Proesmans, Maxim Grymonprez, Sylvie Rottey, Lies Lahousse

Eur Heart J Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.
Andreas Capiau, Els Mehuys, Maxim Grymonprez, Inge Van Tongelen, Thierry Christiaens

Thromb Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, Stephane Steurbaut, Lies Lahousse

Thromb Haemost· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study.
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, Stephane Steurbaut, Lies Lahousse

Eur Heart J Qual Care Clin Outcomes· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis.
Cheima Amrouch, Delphine Vauterin, Souad Amrouch, Maxim Grymonprez, Lu Dai

Drugs Aging· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Maxim Grymonprez, Laura Carnoy, Andreas Capiau, Koen Boussery, Els Mehuys

Eur Heart J Cardiovasc Pharmacother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach.
Andreas Capiau, Maxim Grymonprez, Sophie Scheire, Yenna Faute, Lies Lahousse

Thromb Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine L De Backer, Lies Lahousse

Cardiovasc Drugs Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study.
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, Stephane Steurbaut, Lies Lahousse

Int J Cardiol Heart Vasc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study.
Maxim Grymonprez, Tine L De Backer, Andreas Capiau, Delphine Vauterin, Els Mehuys

Br J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study.
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, M Arfan Ikram, Stephane Steurbaut

Age Ageing· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study.
Maxim Grymonprez, Tine L De Backer, Xander Bertels, Stephane Steurbaut, Lies Lahousse

Front Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study.
Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut, Els Mehuys, Koen Boussery

Front Cardiovasc Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis.
Maxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, Tine L De Backer, Lies Lahousse

Europace· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis.
Maxim Grymonprez, Kevin Vanspranghe, Andreas Capiau, Koen Boussery, Stephane Steurbaut

Br J Clin Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cerebral blood flow in subjects with and without chronic obstructive pulmonary disease from the population-based Rotterdam Study.
Sara R A Wijnant, Daniel Bos, Guy Brusselle, Maxim Grymonprez, Ernst Rietzschel

BMJ Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis